Introduction
============

The H7 subtype of the influenza A virus (IAV) HA gene has been found in combination with all nine NA subtype genes and all H7Nx combinations have been found in wild birds, the natural reservoir of the virus ([@B1]). Live-poultry markets (LPMs) bring together numerous bird and poultry species from different sources in a high-density setting, thus providing an ideal environment for reassortment among avian influenza viruses of different subtypes ([@B24]). The novel influenza A H7N9 viruses first reported in March of 2013 have led to five human epidemics ([@B29]). There is some evidence that the H7N9 AIVs can be directly transmitted from poultry to humans and cause disease although they are of low virulence to poultry ([@B13]; [@B2]; [@B3]). An H7N9 virus with a four basic amino acid insertion in a host protease cleavage site in the hemagglutinin protein was identified in two patients with H7N9 virus infection on February 19, 2017 ([@B30]). Animal infection experiments confirmed that such H7N9 viruses have high virulence in chickens and variable virulence in mice, suggesting a new potential threat to public health and the poultry industry ([@B14]; [@B15]).

Molecular and serological methods have been developed for detecting H7N9 AIVs ([@B4]; [@B9]; [@B15]). Molecular tests include conventional reverse transcriptase polymerase chain reaction (RT-PCR) and real-time RT-PCR (rRT-PCR). For laboratory diagnosis and surveillance, serological tests including the hemagglutinin inhibition (HI) test and enzyme-linked immunosorbent assay (ELISA) are also used ([@B19]; [@B25]; [@B28]). Moreover, the HI test is also the gold standard suggested by the OIE^[1](#fn01){ref-type="fn"}^. However, these conventional methods are time-consuming, require specialized materials and equipment, and occasionally produce false-positive results. The gold immunochromatographic assay (GICA), a technique based on the specific antigen--antibody immunoreactions, is a highly useful tool in diagnostics that can be completed within 30 min, without specialized equipment or complicated handling procedures, providing convenience for rapid testing.

In this study, an inactivated H7N9 virus was used as the immunogen to prepare monoclonal antibodies (McAbs). Antigen epitopes of the McAbs were determined by using antigen escape tests and HA gene sequencing. McAbs with different epitopes were used to develop a gold immunochromatographic strip for detecting H7N9 AIVs.

Materials and Methods {#s1}
=====================

Ethical Approval
----------------

The Jiangsu Administrative Committee for Laboratory Animals approved all animal studies (Permit Number: SYXKSU-2007-0005) according to the guidelines of Jiangsu Laboratory Animal Welfare and Ethical of Jiangsu Administrative Committee of Laboratory Animals.

Viruses
-------

The H7N9 LPAIV strain A/Chicken/Jiangsu/W1-8/2015 (CK/W1-8/15, accession number for HA gene: [MG739458](MG739458)) was isolated from chicken in LPMs in 2015. Other subtype AIVs (**Supplementary Table [S1](#SM1){ref-type="supplementary-material"}**) and avian viruses such as Newcastle disease virus (NDV), adenovirus, avian infectious bronchitis virus (IBV), Marek's disease virus (MDV), and avian infectious bursal disease virus (IBDV) were obtained from the Key Laboratory for Animal Infectious Diseases, Ministry of Agriculture, Yangzhou University, Yangzhou, China and used for specificity tests. All live highly pathogenic avian influenza viruses were handled in the authorized animal biosafety level 3 facilities at Yangzhou University.

Monoclonal Antibodies
---------------------

Monoclonal antibodies against H7N9 AIV were developed following a standard procedure ([@B5]). Briefly, 6-weeks-old BALB/c mice were subcutaneously primed with 20 μg of inactivated H7N9 virus in Freund's adjuvant twice with a 3-week interval, and splenocytes were fused with Sp2/0 myeloma cells 3 days after the last boosting of inactivated H7N9 virus without adjuvant. The hybridomas were screened and selected by hemagglutinin inhibition (HI) assay, and HI titers ≥ 4 were considered positive ([@B8]). The ascitic fluids of positive hybridomas were generated in mice.

Virus Neutralization Test
-------------------------

To identify neutralizing McAbs, the McAbs that yielded positive results in the HI assay were tested in virus neutralization (VN) assays ([@B26]). Briefly, 10-fold serial dilutions of McAbs were mixed with an equal volume of 100 EID~50~ of CK/W1-8/15 virus allantoic fluid and incubated for 1 h at room temperature. The mixture was then injected into 10-days-old specific pathogen-free (SPF) embryonated chicken eggs and incubated for 72 h at 35°C. Allantoic fluids were tested for hemagglutinating activity, and HA titers ≥ 4 were considered positive. The neutralization titers were calculated according to [@B23], and VN titers \< 10 were considered negative.

Selection of Escape Mutants and Nucleotide Sequencing
-----------------------------------------------------

Escape mutants were selected by incubating the McAbs with their parent virus CK/W1-8/15, essentially following the procedure of a previous study ([@B27]; [@B20]). Briefly, the diluent of parental virus (10^6^ EID~50~/0.1 mL) was mixed with an equal volume of ascites fluid containing McAbs. After incubation for 1 h at room temperature, the virus--antibody mixture was injected into 10-days-old SPF embryonated chicken eggs and incubated for 72 h at 35°C. Serial 10-fold dilutions of the positive allantoic fluid (10^-5^, 10^-6^, 10^-7^, and 10^-8^) were mixed with an equal volume of ascites fluid containing McAbs, then the above steps were repeated once. The antigenic character of each isolate was examined using the HI test. The HA gene sequence of each mutant was determined by PCR amplification and sequence analysis ([@B7]), and the deduced amino acid sequence was compared with that of CK/W1-8/15 to identify the epitope recognized by the selective McAb. The escape mutants with more than one mutation in the HA gene were further confirmed by constructing point-mutated rescue viruses using reverse genetics ([@B6]).

Preparation of Colloidal Gold and Colloidal Gold Conjugation
------------------------------------------------------------

Colloidal gold was obtained according to a method described previously ([@B21]). Briefly, the aqueous solution of chloroauric acid \[0.01%, (wt/vol); 100 mL HAuCl~4~\] was heated to the boiling point, followed by the rapid addition of 14 mL of 1% trisodiumcitrate solution with rapid stirring. The reaction mixture was boiled for another 10 min and gradually boiled until the color turned red. The colloidal gold solution was cooled to room temperature and then stored in a dark bottle at 4°C.

McAbs 1B6, 1A11, or 1A2 were add separately to 10 mL of colloidal gold solution and stirred for 30 min. An aqueous solution containing bovine serum albumin (BSA; 10%, wt/vol; 2 mL) was added to block endogenous colloidal gold reactivity. The mixture was then centrifuged at 12,000 rpm and 4°C for 15 min to remove any unbound antibody. The pellet was resuspended in 1 mL of 0.01 M Tris-HCl (pH 8.0; [@B11]).

Preparation of the Immunochromatographic Strip
----------------------------------------------

An immunochromatographic strip that includes a sample pad, a conjugate pad, a nitrocellulose membrane, and an absorbent pad was prepared as shown in **Figure [1](#F1){ref-type="fig"}**. First, the sample pad was saturated with a PBS solution (pH 8.5) containing Tween 20, 1% (wt/vol) BSA, and conjugated antibodies. The sample pad was then dried at 37°C for 1 h. Paired McAbs were microsprayed onto the NC membrane at a concentration of 0.8 mg/mL and localized to specific positions on the strip that were designated as the capture test line (**Figure [1](#F1){ref-type="fig"}**). An anti-IgG antibody was also microsprayed onto the same membrane at a concentration of 1.2 mg/mL and localized to the capture control line. The membrane was dried at 37°C for 2 h. Pure cellulose fiber was used as an absorbent pad. Immunochromatographic strips were store in a desiccator at 4°C prior to use.

![Schematic diagram of the immunochromatographic strip.](fmicb-09-02069-g001){#F1}

Specificity, Sensitivity, and Stability Evaluations of the Developed Strip
--------------------------------------------------------------------------

To evaluate the specificity of the strip, different HA subtypes of AIVs (H1, H3, H4, H5, H6, H8, H9, H10, H11, and H12), serial H7N9 AIVs isolated from year 2013 to 2017 and other avian viruses such as NDV, IBV, MDV, and IBDV were simultaneously tested. An aliquot of 100 μL of each sample was added to the strips and incubated for 15 min at room temperature.

Strip sensitivity was determined using a serial diluted of a positive H7N9 AIV allantoic fluid sample (CK/W1-8/15, HA titer = 256, 10^5^ TCID~50~). The allantoic fluid sample was diluted 1:2, 1:4, 1:8, 1:16, 1:32, 1:64, 1:128, 1:256, 1:512, and 1:1024 with 0.01 M PBS, respectively. These strips were tested to determine their sensitivity in detecting allantoic fluid samples of H7N9 subtype AIVs upon storage at room temperature for 12 months.

Detecting Swab and Lung Samples From Experimentally Infected Chickens
---------------------------------------------------------------------

Three-weeks-old SPF White Leghorn chickens purchased from Beijing Meiliyaweitong Experimental Animal Technology Co., Ltd, were inoculated intranasally with 10^6^ EID~50~ of AIV H7N9 in a 0.2 mL volume (*n* = 10). Trachea and cloacal swabs were collected from chickens at 1, 3, 5, and 7 days post-infection (dpi) and resuspended in 1 mL PBS. In addition, three other chickens were euthanized at 1, 3, 5, and 7 dpi, and the lung samples of infected chickens were subsequently harvested and homogenized in 1 mL PBS. The viral titers of swab and lung samples were determined by EID~50~. An aliquot of 100 μL of each sample was also added to the strip and incubated for 15 min at room temperature.

Evaluation Using Clinical Swab Samples
--------------------------------------

Cloacal swabs (*n* = 200) were collected from apparently healthy poultry in a LPM of Jiangsu province. The swabs were collected in 1 mL PBS supplemented with antibiotics (penicillin 10,000 unit/mL, streptomycin 10 mg/mL, gentamycin 250 μg/mL, kanamycin 250 μg/mL) and subjected to strip detection and virus isolation. After virus isolation, the subtypes of AIV isolates were determined by HI assay or HA gene sequencing.

Results
=======

Selection and Characterization of Monoclonal Antibodies
-------------------------------------------------------

Thirteen McAbs against CK/W1-8/15 HA were generated. The HI titers of the McAbs ranged from 6--13 log2 and the VN titers of the McAbs ranged from 20--2000, indicating that the McAbs were capable of inhibiting the wild type virus in both HI and VN assays (**Table [1](#T1){ref-type="table"}**).

###### 

Biological properties of H7-specific McAbs generated in this study.

  McAb^a^   Isotype   HI titer (log2)   VN titer
  --------- --------- ----------------- ----------
  1C8       IgG~2a~   13                100
  1B6       IgG~2a~   13                316
  1A2       IgG~2a~   12                100
  1C3       IgG~2b~   10                50
  1B9       IgG~2b~   8                 200
  1C9       IgG~2b~   8                 25
  1D12      IgG~2b~   9                 200
  1A11      IgG~1~    6                 20
  1H11      IgG~1~    7                 200
  2F8       IgG~1~    7                 64
  1B10      IgG~2a~   10                1250
  1F12      IgG~2a~   11                2000
  3G4       IgG~2a~   10                640

a

Untreated mouse ascetic fluid of each hybridoma was used in HI and VN assays. Titers shown were the reciprocals of the highest dilutions showing HI or VN activity against CK/W1-8/15 (H7N9) virus.

Escape Mutants
--------------

Escape mutants were selected by inoculating embryonated SPF chicken eggs with CK/W1-8/15 in the presence of the McAbs. HI titers of the McAbs to these resulting mutants were significantly reduced or abolished (**Table [2](#T2){ref-type="table"}**). The result of HA gene sequencing of mutants showed that 13 mutants possessed either one or two amino acid mutations. After confirmation by point-mutated rescue viruses, the positions 235L, 227G, or 198A were found to be the critical amino acid for McAbs recognition.

###### 

Amino acid mutations in the HA of escape mutants from CK/W1-8/15 (H7N9).

  Mutants   HI titer (log2)^a^   Mutations
  --------- -------------------- ----------------
  m1C8      1                    G214E^b^,L235Q
  m1B6      1                    G214E,L235Q
  m1A2      2                    S136G,G227E
  m1C3      0                    A169T, L235Q
  m1B9      0                    A169T, L235Q
  m1C9      0                    A169T, L235Q
  m1D12     1                    A143T, L235Q
  m1A11     2                    A198E
  m1H11     0                    A198E
  m2F8      1                    A198E
  m1B10     0                    L235Q
  m1F12     2                    L235Q
  m3G4      0                    L235Q

a

The HI titers obtained with each selecting McAb against mutants.

b

H7 numbering.

Specificity, Sensitivity, and Stability Evaluations of the Developed Strip
--------------------------------------------------------------------------

Three McAbs 1B6, 1A2, 1A11, which recognized positions 235L, 227G, or 198A, respectively, were screened for conjugation or capture antibodies. After optimization, the McAbs 1B6 and 1A2 were selected as conjugation and capture antibodies, respectively. The specificity results revealed that only H7N9 subtype AIV isolates showed two red lines in the test and control area, while other subtypes AIV and other non-AIV strains showed a single red line in control area (**Figures [2](#F2){ref-type="fig"}**, **[3](#F3){ref-type="fig"}**), indicating that the gold immunochromatographic strip had high specificity for detecting H7N9 AIVs.

![Broad reaction of the strip for H7 subtype AIVs isolated from 2013 to 2017. 1--9: isolated in 2013; 10--17: isolated in 2014; 18, 19: isolated in 2015; 20, 21: isolated in 2016; 22: isolated in 2017; 23: A H7N9 HPAIV stain A/chicken/Hebei/XT-3/2017 (CK/XT-3/2017).](fmicb-09-02069-g002){#F2}

![Strip specificity. 1: H7 positive AIV. 2--12: H1 AIV, H3 AIV, H4 AIV, H5 AIV, H6 AIV, H8 AIV, H9 AIV, H10 AIV, H11 AIV, and H12 AIV. 13--16: NDV, IBV, MDV, and IBDV. 17, 18: PBS and water.](fmicb-09-02069-g003){#F3}

Serial dilutions of the positive H7N9 AIV sample ranging from 2^1^ to 2^10^ were used to determine the sensitivity of the strip. Compared to the hemagglutination test, a HA unit or 10^2.6^ TCID~50~ of H7N9 AIV (1:256 dilution) was successfully detected by using the strip (**Figure [4](#F4){ref-type="fig"}**), indicating that the gold immunochromatographic strip had high sensitivity. After 12 months of storage, the strips still had the same detection limit for H7N9 AIVs as freshly produced strips (**Figure [5](#F5){ref-type="fig"}**).

![Strip sensitivity. Serial dilutions of the positive sample ranging from 2^1^ to 2^10^ were used to determine the sensitivity of the strip. The titer of the positive sample was 2^8^. 1: the positive sample. 2--11: diluted ranging from 2^1^ to 2^10^.](fmicb-09-02069-g004){#F4}

![Strip stability. The sensitivities of fresh strips (left) and strips after 12 months of storage (right) were determined. 1: the positive sample. 2--11: diluted ranging from 2^1^ to 2^10^.](fmicb-09-02069-g005){#F5}

Detection of Swab and Lung Samples From Infected Chickens
---------------------------------------------------------

The distribution of viruses in the swabs (trachea and cloacal) and lung samples were detected at 1, 3, 5, and 7 dpi (**Table [3](#T3){ref-type="table"}**). Virus titers ranged from 1--2.5 log~10~EID~50~/0.1 mL in the swabs, and 1.5--3.5 log~10~EID~50~/0.1 mL in the lung samples. The detection limits in both swabs and lung samples in the strip test were 2.5 log~10~EID~50~/0.1 mL (**Figure [6](#F6){ref-type="fig"}**). These data suggested that the developed strip was suitable for detecting H7N9 AIVs from infected samples.

###### 

Virus titers in swab and lung samples from infected chickens.

  Virus strain   Virus titer (log10 EID~50~ of virus ± SD/0.1 mL)                                                                                                                                                     
  -------------- -------------------------------------------------- ------ ---------- ------------------ ---------------- ---------------- ------------------ ------------ ---------- ------------------ ------------ ----------
  W1-8           5/10^b^ (1.6 ± 0.7)                                0/10   1/3(2.5)   6/10 (1.8 ± 0.7)   2/10 (2 ± 0.5)   3/3(3.2 ± 0.5)   6/10 (1.4 ± 0.2)   1/10 (1.5)   3/3(2.5)   3/10 (1.3 ± 0.2)   1/10 (1.5)   1/3(1.5)

a

dpi = days post-infection;

b

positive number/tested numbers.

![Use of the strip for detecting trachea swabs **(A)**, cloacal swabes **(B)**, and lung samples **(C)** from H7N9 AIV experimentally infected chickens. A-1, B-1, and C-1: H7 positive AIV, A-2: trachea swab sample contained 2.5 log~10~ EID~50~, A-3: trachea swab sample contained 1.5 log~10~EID~50~, B-2: cloacal swab sample contained 2.5 log~10~EID~50~, B-3: trachea swab sample contained 1.5 log~10~EID~50~, C-2: lung sample contained 3.5 log~10~EID~50~, C-3: lung sample contained 2.5 log~10~EID~50~, and C-4: lung sample contained 1.5 log~10~EID~50.~](fmicb-09-02069-g006){#F6}

Detection of Clinical Samples From LPM
--------------------------------------

A total of 200 cloacal swab samples were detected by using the strip and the HA subtypes of AIVs were confirmed by isolation and sequencing (**Table [4](#T4){ref-type="table"}**). The results of the strip assay showed that 3% (6/200) of poultry samples from the LPM were positive for H7N9 AIV, consistent with 4.5% (9/200) as determined by virus isolation, and 3.5% (7/200) as determined by sequencing. Therefore, the sensitivity of the strip compared to the HI assay and PCR assay was 66.7 and 85.7%, and the specificity was 98.5 and 99.5%, respectively. Of the six positive samples determined by the strip assay, two samples contained H7N9 AIVs only, while the other four samples contained H7N9 and H5 subtype AIVs.

###### 

Results from cloacal swab samples from LPM using the strip assay, isolation, and gene sequencing.

  Isolates   Host      The strip assay   HA subtype   Gene sequencing
  ---------- --------- ----------------- ------------ -----------------
  1          Chicken   \+^a^             H7           H7
  2          Chicken   \+                H5/H7        H5/H7
  3          Chicken   \-^b^             H5/H7/H9     H5/H7
  4          Chicken   \+                H5/H7        H5/H7
  5          Chicken   \+                H5/H7        H7
  6          Chicken   \-                H5/H7        H5
  7          Chicken   \-                H5/H7        H5
  8          Chicken   \+                H7           H7
  9          Chicken   \+                H5/H7        H5/H7

a

positive;

b

negative.

Discussion
==========

In 2013, the Chinese Food and Drug Administration (CFDA) approved three PCR kits for specific detection of H7N9 virus. However, no rapid immunoassays for clinical samples have been approved.

In this study, we developed an immunochromatographic strip based on the lateral flow platform using two specific H7-directed McAbs for antigen capture and detection. To avoid possible cross-reactivity and low affinity, the McAbs that recognized different surface epitopes were chosen by further analysis of escape mutants. A total of 13 McAbs were developed, and three epitopes 198A, 227G, and 235L were identified (**Table [2](#T2){ref-type="table"}**). Even though the key amino acids of the epitopes were identical, the HI titers of the different McAbs against the same epitope of corresponding mutants were not the same, which may be due to epitope recognition issues.

[@B16] mapped the five known epitopes of human H3N2 HA onto H7 HA based on the structural comparison of HAs and inferred 130 antigenic sites for the H7 subtype: 18, 22, 27, 41, and 22 antigenic sites for epitopes A, B, C, D, and E, respectively. Furthermore, mutations in epitope D had relatively low frequencies ([@B18]). The positions of the McAbs we developed belonged to two epitopes (198 in epitope B, 227 and 235 in epitope D). We also quantified the spontaneous mutation levels for each of the three amino acid positions (**Table [5](#T5){ref-type="table"}**) by comparing 642 full-length H7 sequences deposited in GenBank. The alignment results revealed that the position 227 had 0% variation rate and was conserved, compared to the other positions. We selected two McAbs 1B6 and 1A2 as conjugation and capture antibodies for the strip.

###### 

Natural mutations at three key amino acid positions in the HA of H7N9 viruses.

  Amino acid position^a^   Mutations (% of isolates bearing each residue)^b^
  ------------------------ ---------------------------------------------------
  227                      G (100), E (0)
  235                      L (86.14), Q (13.86)
  198                      A (92.06), T (7.94), E (0)

a

H7 numbering.

b

A total of 642 full-length H7 sequences available in Genbank was analyzed.

[@B12] developed a rapid diagnostic test for the novel avian influenza A H7N9 virus in patients, with a limit of detection of 10^3.5^ pfu/mL or 10^3^ TCID~50~ of H7N9 virus culture supernatants in 15 min, less sensitive than our strips (10^2.6^ TCID~50~). [@B17] developed a Pen-site Test Kit for the rapid diagnosis of H7 highly pathogenic avian influenza with a limit of detection of 4.5 log~10~EID~50~ for detecting both swab samples and tissue homogenates, less sensitive than our strips (2.5 log~10~EID~50~). [@B10] also developed a GICA for H7N9 AIVs from infected patients, with relatively low sensitivity (33.3%) compared with RT-PCR, and not as good as the sensitivity of our assay (85.7%). Although the rapid immunoassay was less sensitive than rRT-PCR or virus isolation, the strips could detect the clinical samples from LPMs, which could be used as an indicator for H7N9 subtype AIV infections. Highly pathogenic H7N9 subtype avian influenza viruses spread in Southern China and led to massive death of domestic poultry, which may increase the risks for human infections ([@B22]). The strips could also detect the high pathogenic H7N9 subtype AIV (CK/XT-3/2017) from samples. All H7N9 subtype AIVs isolated from 2013 to 2017 were successfully detected by the strip, indicating a broad spectrum for H7N9 AIVs (**Figure [2](#F2){ref-type="fig"}**). Moreover, the strips did not detect the other HA subtype AIVs regardless of high or low HA titer (**Supplementary Table [S1](#SM1){ref-type="supplementary-material"}**). Therefore, the strip is suitable for detecting clinical samples of H7 subtype AIVs (including H7N9 AIVs), either from LPMs or from diseased chickens.
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